C12Y 402/02004
Chondroitin abc lyase , i.e. chondroitinase
Official title: Chondroitin ABC lyase (4.2.2.4), i.e. chondroitinase (C12Y402/0202, C12Y402/02021 take precedence)
C12Y402/02004 (Chondroitin abc lyase , i.e. chondroitinase) appears on 47 US grants and 65 published applications in this corpus.
Search patents in C12Y- Granted patents
- 47
- Published applications
- 65
- Assignees
- 23
- Inventors
- 73
- Latest grant
- 7 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 2 |
| 2003 | 2 | 1 |
| 2004 | 0 | 0 |
| 2005 | 1 | 3 |
| 2006 | 2 | 3 |
| 2007 | 0 | 2 |
| 2008 | 2 | 3 |
| 2009 | 3 | 6 |
| 2010 | 2 | 2 |
| 2011 | 3 | 4 |
| 2012 | 2 | 1 |
| 2013 | 2 | 4 |
| 2014 | 5 | 4 |
| 2015 | 2 | 4 |
| 2016 | 3 | 1 |
| 2017 | 4 | 4 |
| 2018 | 2 | 5 |
| 2019 | 3 | 3 |
| 2020 | 0 | 2 |
| 2021 | 0 | 1 |
| 2022 | 1 | 3 |
| 2023 | 2 | 3 |
| 2024 | 2 | 2 |
| 2025 | 1 | 2 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Targeted chondroitinase ABC fusion proteins and complexes thereof7 Jul 2026US 12,674,155 B2University of Florida Research Foundation, Inc.
- Pharmaceutical composition, package and method for producing the same18 Feb 2025US 12,226,463 B2Seikagaku Corporation
- Package and method for producing the same17 Sep 2024US 12,090,228 B2Seikagaku Corporation
- Therapeutic agent for disc herniation2 Apr 2024US 11,944,670 B2Seikagaku Corporation
- Vesicles comprising a PTEN inhibitor and uses of same16 May 2023US 11,648,260 B2Ramot at Tel-Aviv University Ltd.
- Pharmaceutical composition, package and method for producing the same5 Jun 2025US 2025/0177499 A1Seikagaku Corporation
- Therapeutic agent for disc herniation16 Jan 2025US 2025/0018018 A1Seikagaku Corporation
- Package and method for producing the same5 Dec 2024US 2024/0398712 A1Seikagaku Corporation
- Chondroitin-producing recombinant cell28 Nov 2024US 2024/0392335 A1Givaudan SA
- Vesicles comprising a pten inhibitor and uses of same19 Oct 2023US 2023/0330130 A1Ramot at Tel-Aviv University Ltd.
Most cited
By later US patents
- Methods of repairing connective tissues151US 5,916,557 AInternational Technology Management Associates, Ltd. · 1999
- Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof40US 6,569,661 B1Biomarin Pharmaceutical Inc. · 2003
- Methods for treating diseases caused by deficiencies of recombinant alpha-L-iduronidase38US 6,858,206 B22005
- Human chondroitinase glycoprotein (CHASEGP), process for preparing the same, and pharmaceutical compositions comprising thereof33US 7,544,499 B2Halozyme, Inc. · 2009
- Recombinant α-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiencies thereof24US 6,426,208 B1Harbor-UCLA Research and Education Institute · 2002